Unilabs pursues its strategy in Portugal
May 31, 2006
Unilabs announces that it has concluded an agreement to acquire its second clinical testing laboratory in Portugal. This agreement relates to a laboratory and its patient service centers, which presently achieve revenues of Euros 4.2 million per year and are located in a major city. The laboratory holds a significant market share in its area, also providing services to hospitals and private clinics.
According to the agreement, Unilabs acquires a 100% interest in the capital of the laboratory. The transaction will be effective on June 1, 2006.
For Unilabs, this latest acquisition represents a further step towards reaching a critical mass that will allow the realization of further synergies in Portugal, as well as the possibility to develop its services to the private clinical and hospital segments.
About Unilabs
The Unilabs Group (SWX: ULB) is the European leader of clinical testing laboratories. With over 50 laboratories and over 1500 employees operating in 6 countries, Unilabs tests over 3.5 million samples per year using more than 1500 different tests. Unilabs’ clinical testing services are used by over 60 public and private hospitals in France, Spain and Switzerland. Unilabs has been listed on the SWX Swiss Stock Exchange since 1997.
Edgard Zwirn, Executive Chairman, is at your disposal for any further query (tel. +4122 909 77 77). Our press releases are also available on the Internet at our web site www.unilabs.ch
WebWireID14689
- Contact Information
- Edgard Zwirn
- Executive Chairman
- Unilabs Group
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.